TriPath Imaging in preferred provider deal:
This article was originally published in Clinica
Executive Summary
TriPath Imaging has formed an agreement with the San Antonio, Texas-based International Cancer Screening Laboratory for the use of TriPath's AutoCyte PREP system for the detection of cervical cancer. Under the agreement, Burlington, North Carolina-based TriPath becomes ICSL's preferred provider of thin-layer preparations for three years. ICSL processes over 500,000 Pap tests annually.